T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 06/30/2016
Volatility and Other Measures
as of 06/30/2016
Beta 0.92
0.37
Standard Deviation 16.84
Price/Earnings Ratio (Domestic) 19.1
Earnings Growth Rate (Domestic) 12.5
Turnover Rate 9.9
Median Market
Capitalization
$32,831.11 Million
Sector Diversification
as of 06/30/2016
% of Total Net Assets
Services 36.2%
Biotechnology 24.3%
Pharmaceuticals 18.5%
Products & Devices 11.7%
Life Sciences 6.6%
10 Largest Holdings
Represents 35.82 % of Total Net Assets
View Holdings as of:
Aetna
Allergan
Becton, Dickinson & Company
Bristol-Myers Squibb
Cigna
Gilead Sciences
Humana
McKesson
Thermo Fisher Scientific
UnitedHealth Group
As of 06/30/2016 the Health Sciences Fund had a total of 138 holdings.
See Glossary for additional details on all data elements.